Hansoh signs $690M ADC pact with fellow Chinese biotech Biotheus
Biotheus Expanded Their Partnership with Hansoh Pharma for Developing EGFR/cMET Bispecific Antibody-Drug Conjugates
PALO ALTO, Calif., and ZHUHAI, China, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Bitterroot Bio, a leader in innovative treatments for cardiovascular diseases, and Biotheus, a pioneer in monoclonal and...
BioNTech inks $1 B oncology deal with Chinese startup Biotheus
BioNTech cancer work takes center stage with 2 deals
BioNTech has reached a research and option agreement with Biotheus for two antibody candidates.